v3.26.1
STOCKHOLDERS’ EQUITY
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 11 – STOCKHOLDERS’ EQUITY

 

At-the-Market Offerings

 

The Company has entered into an at-the-market offering agreement with H.C. Wainwright & Co., LLC, as sales agent, relating to the sale of common stock. During the six months ended June 30, 2026, the Company sold 820,800 shares of common stock and received approximately $1,458,000 of gross proceeds before deducting sales agent commissions and offering expenses. The net proceeds received by the Company from these transactions amounted to approximately $1,411,000, and will be used for working capital and general corporate purposes.

 

Warrants

 

There were no grants or exercises of warrants during the six months ended June 30, 2026.

 

During the six months ended June 30, 2026, the following warrants expired unexercised:

 

● Series B warrants to purchase an aggregate of 35,700 shares of common stock at an exercise price of $5.00 per share;

 

● Series D warrants to purchase an aggregate of 148,567 shares of common stock at an exercise price of $6.00 per share;

 

● Series F warrants to purchase an aggregate of 210,528 shares of common stock at an exercise price of $9.50 per share; and

 

● certain underwriter / placement agent warrants to purchase 769 shares of common stock at an exercise price of $6.25 per share.